The drug development sector in the United States is experiencing a significant surge in demand for Tirzepatide APIs. This potent medication, used to treat glucose intolerance, has attracted considerable attention from both individuals and medical practitioners. As a result, numerous manufacturers have emerged as suppliers of Tirzepatide APIs in the